156 related articles for article (PubMed ID: 25758544)
1. Drugs for ADHD.
Med Lett Drugs Ther; 2015 Mar; 57(1464):37-40. PubMed ID: 25758544
[No Abstract] [Full Text] [Related]
2. Aptensio XR--another long-acting methylphenidate.
Med Lett Drugs Ther; 2015 Jul; 57(1473):101-3. PubMed ID: 26204039
[No Abstract] [Full Text] [Related]
3. Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder.
Elia J; Wilson Z; La Porta LS; Algon SA; Prowler ML; Cartwright ST; McKenna PA; Laracy S; Takeda T; Borgmann-Winter K
Expert Rev Clin Pharmacol; 2011 May; 4(3):311-28. PubMed ID: 22114778
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
[No Abstract] [Full Text] [Related]
5. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
Golubchik P; Sever J; Weizman A
Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
[TBL] [Abstract][Full Text] [Related]
6. QuilliChew ER--extended-release chewable methylphenidate tablets.
Med Lett Drugs Ther; 2016 May; 58(1495):68-9. PubMed ID: 27192619
[No Abstract] [Full Text] [Related]
7. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
[No Abstract] [Full Text] [Related]
8. Optimizing ADHD therapy with sustained-release methylphenidate.
Lawrence JD; Lawrence DB; Carson DS
Am Fam Physician; 1997 Apr; 55(5):1705-9, 1711-2. PubMed ID: 9105199
[TBL] [Abstract][Full Text] [Related]
9. Effects of switching to once-daily modified-release methylphenidate from previous treatment with other psychostimulants in children and adolescents with ADHD: an observational study with clinician, parent, and teacher evaluations.
Frölich J; Breuer D; Görtz-Dorten A; Amonn F; Fischer R; Döpfner M
J Clin Psychopharmacol; 2014 Feb; 34(1):168-71. PubMed ID: 24346749
[No Abstract] [Full Text] [Related]
10. Clinical inquiries. Is methylphenidate useful for treating adolescents with ADHD?
Mott TF; Leach L; Johnson L
J Fam Pract; 2004 Aug; 53(8):659-61. PubMed ID: 15298843
[No Abstract] [Full Text] [Related]
11. Flawed attention-deficit/hyperactivity disorder medication comparison.
Adesman A
Pediatrics; 2004 Oct; 114(4):1132; author reply 1132-3. PubMed ID: 15466129
[No Abstract] [Full Text] [Related]
12. Transdermal methylphenidate system: old wine in a new bottle.
Bukstein OG
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):661-5. PubMed ID: 19442029
[TBL] [Abstract][Full Text] [Related]
13. Focalin XR for ADHD.
Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
[No Abstract] [Full Text] [Related]
14. The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD.
Childress A; Sallee FR
Expert Rev Neurother; 2013 Sep; 13(9):979-88. PubMed ID: 24053342
[TBL] [Abstract][Full Text] [Related]
15. Treating attention-deficit/hyperactivity disorder with a stimulant transdermal patch: the clinical art.
Arnold LE; Lindsay RL; López FA; Jacob SE; Biederman J; Findling RL; Ramadan Y
Pediatrics; 2007 Nov; 120(5):1100-6. PubMed ID: 17974748
[TBL] [Abstract][Full Text] [Related]
16. Clinical and cognitive response to extended-release methylphenidate (Medikinet) in attention deficit/hyperactivity disorder: efficacy evaluation.
Fernández-Jaén A; Fernández-Mayoralas DM; Pardos A; Calleja-Pérez B; Muñoz Jareño N
Adv Ther; 2009 Dec; 26(12):1097-110. PubMed ID: 20082241
[TBL] [Abstract][Full Text] [Related]
17. Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.
Lewis H; Lewis J
Atten Defic Hyperact Disord; 2012 Mar; 4(1):37-9. PubMed ID: 22311620
[TBL] [Abstract][Full Text] [Related]
18. Newly approved once-daily formulations of medications for the treatment of Attention Deficit (Hyperactivity) Disorder (ADHD) in children and adolescents.
Roman MW
Issues Ment Health Nurs; 2010 Aug; 31(8):548-9. PubMed ID: 20624025
[No Abstract] [Full Text] [Related]
19. Extended-release Methylphenidate Treatment and Outcomes in Comorbid Social Anxiety Disorder and Attention-deficit/Hyperactivity Disorder: 2 Case Reports.
Koyuncu A; Çelebi F; Ertekin E; Kahn DA
J Psychiatr Pract; 2015 May; 21(3):225-31. PubMed ID: 25955266
[TBL] [Abstract][Full Text] [Related]
20. Sixty seconds on . . . ADHD.
Hawkes N
BMJ; 2015 Nov; 351():h6294. PubMed ID: 26612410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
